CLRB – cellectar biosciences, inc. (US:NASDAQ)
Stock Stats
News
NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225) [Yahoo! Finance]
NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $14.00 to $12.00. They now have an "outperform" rating on the stock.
Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
Form 8-K Cellectar Biosciences, For: Nov 18
Form 10-Q Cellectar Biosciences, For: Sep 30
Form 8-K Cellectar Biosciences, For: Nov 15
Form SCHEDULE 13G/A Cellectar Biosciences, Filed by: Nantahala Capital Management, LLC
Form SC 13G/A Cellectar Biosciences, Filed by: ADAR1 Capital Management, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.